Meeting
2014 ASCO Annual Meeting
NY-ESO-1 specific CD4+ Thelper1 cells for immunotherapy of cancer.
Authors
Simone Kayser
University Children's Hospital, Tübingen, Germany
Simone Kayser , Cristina Boß , Michael Schumm , Judith Feucht , Stefan Stevanovic , Peter Lang , Rupert Handgretinger , Claus Garbe , Martin Röcken , Tobias Feuchtinger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Immunotherapy
Track
Developmental Therapeutics
Sub Track
Immunotherapy and Biologic Therapy
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3071)
DOI
10.1200/jco.2014.32.15_suppl.3071
Abstract #
3071
Poster Bd #
138
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Trial in progress: Natural killer (NK) cells with TGFβ receptor I inhibitor vactosertib and IL-2 in patients with metastatic colorectal cancer or hematologic malignancies.
First Author: J. Eva Selfridge
Poster
2022 ASCO Genitourinary Cancers Symposium
Immune characterization of urothelial bladder carcinoma integrating transurethral resection of bladder tumor (TURBT) samples and serum: A feasibility study.
First Author: Carmen Alvarez-Dominguez
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Targeting autophagy and immunotherapy with hydroxychloroquine and interleukin 2 in patients with metastatic renal cell carcinoma (mRCC): A Cytokine Working Group study.
First Author: Leonard Joseph Appleman
Poster
2024 ASCO Breakthrough
Investigation of the effect of macrophage and epithelial cell interaction in the progression of different subtypes of breast cancer.
First Author: Banani Majumdar